Navigation Links
Adnavance Technologies Inc. Appoints Christian P. Valcke, Ph.D., to Its Scientific Advisory Board
Date:5/13/2008

VANCOUVER, British Columbia and SAN DIEGO, May 13 /PRNewswire/ -- Adnavance Technologies Inc., a developer of direct detection molecular diagnostic tests for medical applications, announced today that it has appointed Christian P. Valcke, Ph.D., to its Scientific Advisory Board. Dr. Valcke has more than 20 years of experience in all aspects of product development, including design, validation, manufacturing and clinical development for medical and diagnostic devices.

Dr. Valcke currently serves as the Senior Director of Instrument Systems at Novartis Vaccines and Diagnostics (NVS), a new division formed as a result of its acquisition of Chiron Corporation. He was previously Vice President of Research and Development at Nanomix, a nanotechnology startup company. Prior to that, Dr. Valcke held several leadership positions at Nanogen, a molecular diagnostics and point-of-care testing company. He has also authored dozens of published research articles and patents.

"Chris is a creative and innovative medical device engineer whom I had the pleasure of working with at Nanogen, and I look forward to working with him again. His contributions, together with Marcelo Baru, our Director of Engineering, will help optimize our direct detection M-DNA platform," said Randy White, Adnavance CEO.

Adnavance Technologies' proprietary ultra-sensitive M-DNA(TM) direct detection technology may eliminate the need for target amplification for a large number of molecular diagnostic tests. Only about 10% of all hospital laboratories and only 35% of all independent laboratories in the U.S. perform molecular diagnostic testing. Adnavance's platform technology has the potential to de-centralize molecular testing and open the market to approximately 30,000 new customers who are currently not licensed to perform medical tests.

"The Company's ultra-sensitive M-DNA technology is new and doesn't rely on light detection, which is an exciting development for a medical
'/>"/>

SOURCE Adnavance Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sturgeon and Caviar From Aquaculture: United Food Technologies AG Hands Over Turnkey Plant
2. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
3. Veran Medical Technologies Secures $4.75M in First Institutional Funding
4. Neurobiological Technologies Reports Third Quarter Financial Results
5. InSet Technologies Appoints Jon Tremmel to its Board of Directors
6. Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism
7. Neurobiological Technologies Sets Date for Third Quarter Financial Results
8. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
9. Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results
10. Dilon Technologies Receives CE Mark for Medical Imaging System
11. MultiCell Technologies Relocates Corporate Headquarters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 According to ... Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web ... Forecasts & Trends to 2018", published by MarketsandMarkets, analyzes ... geographies such as North America , ... , and the Rest of the World (RoW). ...
(Date:7/29/2014)... 2014 /PRNewswire-iReach/ -- Nanosyn, Inc. announced today a ... to provide access to Nanosyn,s microfluidics screening and ... for novel small molecule therapeutics. ... work with FORMA Therapeutics to explore key pathways ... FORMA Therapeutics, decision to work with us is ...
(Date:7/29/2014)... Colo. , July 29, 2014  Cannabis ... in cannabis formulation-based drug development and related consulting, ... Times for taking a strong position in opposition ... Sunday, July 27, 2014 publication.  The New York ... and articles this week exploring the issue called ...
(Date:7/29/2014)... Denver, CO (PRWEB) July 29, 2014 ... and soiled linen collection and transport solutions for hospitals, ... Society for Healthcare Engineering (ASHE) Annual Conference & Technical ... TransVac will present its technology for making hospitals cleaner, ... operational costs over the hospital’s life cycle. Staff ...
Breaking Biology Technology:Digital Pathology Market worth $437 Million by 2018 2Digital Pathology Market worth $437 Million by 2018 3Nanosyn Announces Expanded Partnership With FORMA Therapeutics 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 3TransVac Presents Cost Saving Technology at ASHE Conference for Keeping Hospitals Cleaner 2
... LOUIS, Jan. 24 The National Academy of,Sciences ... Fraley, Ph.D.,chief technology officer and executive vice president ... the Industrial Application of Science. This,prize is awarded ... importance and with significant, beneficial applications in,industry -- ...
... Bard, professor of chemistry and biochemistry at The University ... Prize in Chemistry jointly with Professor William Moerner of ... of education, Professor Yuli Tamir, was given to the ... of science, single-molecule spectroscopy and imaging. , The $100,000 ...
... million grows 32% year-over-year, - Operating income increases 47.7%, diluted ... - Backlog increases 41% to a record of ... - Net quarterly book-to-burn ratio equates to 1.9, BOSTON, ... its financial results for the,second quarter ended December 31, 2007., ...
Cached Biology Technology:National Academy of Sciences Recognizes Monsanto's Chief Technology Officer for Development of Agricultural Biotechnology 2PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 3PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 4PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 5PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 6PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 7PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 8PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 9PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 10
(Date:7/29/2014)... sometimes need to get back to basics. UC ... study the impacts of the bumphead parrotfish ( ... two remote locations in the central Pacific Ocean. ... simulation, McCauley, an assistant professor in the Department ... colleagues sought to understand whether the world,s largest ...
(Date:7/29/2014)... effects of a stroke is an immensely complex ... well as effective therapy. Advancing such knowledge to ... primary focus of research by Sergei Adamovich, associate ... NJIT faculty more than a decade ago. It ... funding from sources such as the National Institutes ...
(Date:7/29/2014)... (UM SOD) and Medicine (UM SOM) jointly announced ... million grant award from the National Institute of ... Institutes of Health to study the causes, prevention ... which renews a previous $12 million five-year NIAID-funded ... research by studying chlamydial and gonorrheal diseases as ...
Breaking Biology News(10 mins):Underwater elephants 2Underwater elephants 3Continuing the quest for better stroke therapies 2Continuing the quest for better stroke therapies 3University of Maryland Schools of Dentistry and Medicine receive NIH grant 2University of Maryland Schools of Dentistry and Medicine receive NIH grant 3University of Maryland Schools of Dentistry and Medicine receive NIH grant 4
... islet cells from pigs may be used in clinical ... diabetes. This key finding was the discovery ... Institute for Immunology & Transplantation at the University of ... in the prestigious scientific journal Nature Medicine in March ...
... MICROSCOPY -- A chorus of signals . . . ... scanning probe microscopy, moves the field towards probing energy ... probe microscopes measure the cantilevers movements over the surface ... excitation excites and detects response over a continuous band ...
... of UPMC have identified a potential target for ... the most prevalent sexually transmitted bacterial infection in ... Darville, MD, chief of the Division of Pediatric ... of Chlamydia that, when investigated in an animal ...
Cached Biology News:Breakthrough research identifies how cells from pigs may cure diabetes 2Story tips from the US Department of Energy's Oak Ridge National Laboratory, September 2007 2Story tips from the US Department of Energy's Oak Ridge National Laboratory, September 2007 3Study by Pittsburgh researchers identifies possible vaccine target for chlamydia 2
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Rabbit anti-NFkB p105/p50 (Ser337) Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Biology Products: